Stocks · Health care · Pharmaceutical Preparations

Viatris

VTRS Clue Score21
United States Fiscal year ends December CIK 0001792044 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Paul Campbell
25 Jun 2026
See Remarks
Sold on a plan
50,076
$16.17
$809.78K
Paul Campbell
23 Mar 2026
See Remarks
Sell
21,350
$13.28
$283.54K
David S Simmons
3 Nov 2025
Director
Buy indirect
213
$10.43
$2.22K
Goff Corinne Le
11 Sep 2025
Chief Commercial Officer
Sold on a plan
7,032
$10.25
$72.04K
David S Simmons
27 Aug 2025
Director
Buy indirect
286
$10.42
$2.98K
Scott Andrew Smith
12 Aug 2025
Chief Executive Officer
Buy
22,000
$9.99
$219.74K
Scott Andrew Smith
12 May 2025
Chief Executive Officer
Buy
60,000
$8.94
$536.26K
Paul Campbell
11 Nov 2024
See Remarks
Sell
26,925
$12.88
$346.69K
Rajiv Malik
12 Sep 2024
Director
Sell
139,681
$11.66
$1.63M
Rajiv Malik
12 Sep 2024
Director
Sell indirect
60,319
$11.71
$706.55K
Rajiv Malik
30 Aug 2024
Director
Sell indirect
50,000
$12.00
$600.00K
Rajiv Malik
28 Aug 2024
Director
Sell indirect
50,000
$11.90
$595.08K
Rajiv Malik
23 Aug 2024
Director
Sell indirect
100,000
$11.75
$1.18M
Rajiv Malik
22 Aug 2024
Director
Sell indirect
100,000
$11.73
$1.17M
Rajiv Malik
21 Aug 2024
Director
Sell indirect
100,000
$11.75
$1.18M
Rajiv Malik
14 Jun 2024
Director
Sell
264,300
$10.18
$2.69M
Rajiv Malik
13 Jun 2024
Director
Sell
85,660
$10.52
$900.74K
Brian Roman
28 May 2024
Chief Legal Officer
Sell
89,419
$10.38
$928.43K
Anthony Mauro
13 Mar 2024
See Remarks
Sell
250,000
$12.09
$3.02M
Dillon JoEllen Lyons
5 Mar 2024
Director
Sold on a plan
20,000
$12.36
$247.20K
Paul Campbell
5 Mar 2024
See Remarks
Sell
24,353
$12.33
$300.27K
Xiangyang (Sean) Ni
4 Mar 2024
President, Greater China
Sold after exercise
3,777
$12.36
$46.68K
Xiangyang (Sean) Ni
4 Mar 2024
President, Greater China
Sold after exercise
17,755
$12.54
$222.64K
Andrew Cuneo
23 Feb 2024
See Remarks
Sold on a plan
4,000
$13.50
$54.00K
Andrew Cuneo
15 Feb 2024
See Remarks
Sold on a plan
4,000
$12.50
$50.00K
Andrew Cuneo
4 Jan 2024
See Remarks
Sold on a plan
4,000
$11.50
$46.00K
Andrew Cuneo
14 Dec 2023
See Remarks
Sold on a plan
4,000
$10.50
$42.00K
Xiangyang (Sean) Ni
24 Nov 2023
President, Greater China
Sell
14,937
$9.37
$139.94K
Harry Korman
26 Oct 2023
Director
Buy
19
$9.01
$171.13
Xiangyang (Sean) Ni
6 Mar 2023
President, Greater China
Sell
3,148
$11.08
$34.89K
Xiangyang (Sean) Ni
3 Mar 2023
President, Greater China
Sell
3,093
$11.18
$34.58K
Xiangyang (Sean) Ni
28 Feb 2023
President, Greater China
Sell
5,250
$11.22
$58.89K
Xiangyang (Sean) Ni
25 Nov 2022
President, Greater China
Sell
12,800
$10.95
$140.22K
der Meer Mohr Pauline van
17 Aug 2022
Director
Sell
9,440
$10.58
$99.91K
Menassie Taddese
27 May 2022
See Remarks
Sell
8,813
$12.07
$106.41K
Harry Korman
16 Mar 2022
Director
Buy
239
$10.42
$2.49K
Michael Goettler
15 Mar 2022
Chief Executive Officer
Buy
50,352
$9.87
$496.77K
W Don Cornwell
15 Mar 2022
Director
Buy
2,700
$9.90
$26.72K
Robert J Coury
11 Mar 2022
Executive Chairman
Sell indirect
250,000
$10.07
$2.52M
Robert J Coury
9 Mar 2022
Executive Chairman
Sell indirect
250,000
$10.28
$2.57M
Harry Korman
4 Mar 2022
Director
Buy
1,150
$10.08
$11.59K
Harry Korman
16 Dec 2021
Director
Buy
176
$12.84
$2.26K
Harry Korman
16 Sep 2021
Director
Buy
162
$13.81
$2.24K
Harry Korman
16 Jun 2021
Director
Buy
145
$15.39
$2.23K
W Don Cornwell
21 May 2021
Director
Buy
500
$15.45
$7.73K
W Don Cornwell
19 May 2021
Director
Buy
1,500
$15.79
$23.69K
Harry Korman
9 Mar 2021
Director
Buy
349
$13.94
$4.86K
W Don Cornwell
3 Mar 2021
Director
Buy
3,000
$13.84
$41.51K
Harry Korman
25 Feb 2021
Director
Buy
713
$14.97
$10.67K
Harry Korman
15 Jan 2021
Director
Buy
837
$16.99
$14.22K
James M Kilts
16 Dec 2020
Director
Buy
27,736
$17.66
$489.69K
Harry Korman
11 Dec 2020
Director
Buy
613
$17.15
$10.51K

What was left out

Form 4 filings counted 280
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 2
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 1,394,932,371
Sales filed before the plan box existed 8
History held since 16 Nov 2020